Austin
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
212- Dermatology
- 150
- Plastic Surgery
- 62
Vendor qualification for Austin medspas and aesthetic practices
Because a medspa operates under physician supervision, the supervising physician's practice is usually the one running vendor qualification: confirming the distributor sells only to licensed accounts, confirming pricing is reserved for verified accounts rather than published anywhere, and confirming registration and licensure documentation is available for direct review.
Wharton's jelly products in this category are not stem cell therapies, and commercial cord-tissue allografts are not documented to contain viable, functional stem cells; practices should ask a distributor for its processing description and lot documentation rather than rely on general category language.
Documentation to request before stocking a lot
The same checklist applies across Wharton's jelly and exosome formats, with one addition for exosome products.
- Certificate of analysis for the specific lot
- Donor eligibility summary
- Lot release record
- For exosome products, characterization data such as particle concentration method and marker panel, on request
Receiving shipments in Texas
Cryopreserved formats ship overnight on dry ice in validated containers and are stored at -80 degrees C until use; lyophilized Wharton's jelly and exosome formats ship shelf-stable and are stored and reconstituted per the insert included with the lot. Clinical or front-desk staff should log each shipment's lot identifier against the packing slip before it enters inventory.
Confirm your regulatory posture directly
Dermatology and plastic surgery practices should route questions about how a specific product fits their regulatory framework, including any Texas-specific requirements, to their own counsel and, where relevant, the Texas Medical Board, rather than to a supplier. Precision Biologics supports the procurement side of that process: NPI verification, documentation on request, and physician-level calls about product documentation.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does the supervising physician need to be named on our medspa's account?+
Accounts are verified through an NPI number for a licensed provider, so the supervising physician's credentials are typically part of account setup.
Are these products marketed as stem cell treatments?+
No. Precision Biologics does not market Wharton's jelly products as stem cell therapies, and commercial cord-tissue allografts are not documented to contain viable, functional stem cells.
What should we check before using a new lot in the practice?+
Request the certificate of analysis, donor eligibility summary, and lot release record for that lot, and confirm the lot identifier on the shipment matches your paperwork.